Devices › Automated external defibrillators (non-wearable)
Device brand name · Defibrillator
HeartStart MRx monitor/defib: medical device reports filed with FDA
3,776 reports name it, 2021–2026. Manufacturer given most often on reports: Philips North America. Product code MKJ.
- 3,776
- device reports naming the brand
- 0% of all MAUDE reports · about 708 a year
- 107
- reports, 12 months to August 2026
- 290 in the 12 months before
- 98.1%
- classified as malfunction
- 96.8% across the product code
- 0.5%
- classified as death, as reported
- 17 reports · not verified by FDA
FDA's MAUDE database holds 3,776 reports that name the brand "HeartStart MRx monitor/defib" (defibrillator), received between March 2021 and August 2026; the manufacturer given most often on reports is Philips North America. Spellings of one product vary from report to report.
107 reports arrived in the 12 months to August 2026, down 63% from 290 in the 12 months before. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases. The event types recorded are malfunction (98.1%), injury (1.4%) and death (0.5%); across all automated external defibrillators (non-wearable) reports (product code MKJ) death is recorded in 1.7% and malfunction in 96.8%. Event type is the reporter's classification of the report, not a verified outcome.
The device problems coded most often are failure of device to self-test (27.6%), battery problem (12.1%) and electrical /electronic property problem (11%). The patient problems coded most often are appropriate clinical signs, symptoms and conditions term/code not available, cardiac arrest and burn(s). FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Reports by month, five years
Reports by the month FDA received them. FDA releases MAUDE data monthly; reports can arrive months after an event, so the newest months grow in later releases.
By year received
Event type and report source
Event type, as classified on the report
Who filed the report
Grey bar: all 269,686 reports carrying product code MKJ. Event type is the filer's classification and is not verified by FDA.
Device problems coded
| Device problem (FDA code) | Reports | Share | Share across product code |
|---|---|---|---|
| Failure of device to self-test | 1,042 | 27.6% | 8.9% |
| Battery problema problem with the battery | 456 | 12.1% | 2.5% |
| Electrical /electronic property probleman electrical or electronic problem | 414 | 11% | 1.9% |
| Defibrillation/stimulation problem | 271 | 7.2% | 3.2% |
| Power problem | 237 | 6.3% | 1% |
| Failure to power up | 136 | 3.6% | 13% |
| Failure to charge | 119 | 3.2% | 2.5% |
| Failure to deliver shock/stimulation | 118 | 3.1% | 1.8% |
| Unable to obtain readings | 94 | 2.5% | 4.4% |
| Energy output problem | 90 | 2.4% | 0.4% |
| Failure to calibrate | 75 | 2% | 0.2% |
| Output below specifications | 75 | 2% | 0.2% |
| Display or visual feedback problem | 66 | 1.7% | 0.5% |
| Fracturea broken bone | 65 | 1.7% | 0.1% |
| Incorrect, inadequate or imprecise result or readings | 53 | 1.4% | 1.3% |
| Sparking | 50 | 1.3% | 0.2% |
| Material integrity problema problem with the device material | 49 | 1.3% | 0.1% |
| Noise, audible | 48 | 1.3% | 0.4% |
| Charging problem | 47 | 1.2% | 0.6% |
| Failure to run on battery | 46 | 1.2% | 0.1% |
FDA's device problem codes as entered on the report; one report can carry several. Generic codes such as "no apparent adverse event" are left out.
Patient problems coded
| Patient problem (FDA code) | Reports | Share |
|---|---|---|
| Appropriate clinical signs, symptoms and conditions term/code not available | 17 | 0.5% |
| Cardiac arrestthe heart stopped | 13 | 0.3% |
| Burn(s)a burn | 7 | 0.2% |
| Myocardial infarctionheart attack | 4 | 0.1% |
| Atrial fibrillationan irregular heart rhythm | 3 | 0.1% |
| Ventricular fibrillationa chaotic rhythm from the lower heart chambers | 3 | 0.1% |
| Respiratory failurethe lungs could not supply enough oxygen | 2 | 0.1% |
| Tachycardiafast heart rate | 2 | 0.1% |
| Arrhythmia | 1 | 0% |
| Asystole | 1 | 0% |
| Bradycardiaslow heart rate | 1 | 0% |
| Electric shockan electric shock | 1 | 0% |
| Heart block | 1 | 0% |
| Loss of consciousnesspassing out | 1 | 0% |
Patient problem codes are present mainly in reports filed since 2019 and are often blank.
In context
| Measure | HeartStart MRx monitor/defib | Product code MKJ | All MAUDE reports |
|---|---|---|---|
| Reports | 3,776 | 269,686 | 26,136,888 |
| Share of that pool | — | 1.4% | 0% |
| Classified as death, per 1,000 reports | 5 | 17 | 9 |
| Classified as injury | 1.4% | 0.7% | 36.2% |
| Classified as malfunction | 98.1% | 96.8% | 62.3% |
| Filed by the manufacturer | 100% | 99.3% | 94.9% |
Shares are of reports, not of devices in use. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data."
Other brands with product code MKJ
| Brand | Reports | Latest 12 months | Classified as death |
|---|---|---|---|
| M Series | 27,112 | 4 | 2.3% |
| Heartstart Mrx | 18,592 | 0 | 0.7% |
| HeartStart MRx -EMS Defibrillator | 16,166 | 33 | 0.8% |
| Heart Start XL | 15,944 | 95 | 0.9% |
| R Series Defibrillator | 15,393 | 0 | 0.9% |
| X Series | 13,983 | 1,692 | 2.7% |
| HeartStart XL+ Defibrillator/Monitor | 13,188 | 210 | 0.4% |
| Heartstart Onsite | 10,964 | 0 | 0.8% |
| Aed Plus | 9,225 | 423 | 2.2% |
| Heartsine Samaritan 300p And Pad Pak | 8,197 | 0 | 0.3% |
| E Series Defibrillator | 8,052 | 0 | 1.5% |
| Lifepak R 15 Monitor/Defibrillator | 6,117 | 463 | 1.4% |
| Heartstart Frx | 5,978 | 2 | 1.3% |
| Efficia Dfm100 | 5,076 | 0 | 0.6% |
| LIFEPAK 15 defibrillator/monitor | 4,716 | 369 | 1% |
Ordered by report count for navigation only. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA also states that "common products may have a higher number of adverse events due to the higher total number of people using the product."
Questions about HeartStart MRx monitor/defib reports
How many FDA reports name HeartStart MRx monitor/defib?
3,776 medical device reports in the openFDA MAUDE release of 28 Sep 2026, covering reports received through August 2026; 107 in the latest 12 months.
What kinds of events are reported?
malfunction (98.1%), injury (1.4%) and death (0.5%). "Event type" is how the report was classified when filed: death, injury, malfunction or other.
What device problems are coded?
failure of device to self-test (27.6%), battery problem (12.1%), electrical /electronic property problem (11%), defibrillation/stimulation problem (7.2%) and power problem (6.3%). These are FDA's device problem codes as entered on the report.
Who files these reports?
manufacturer reports (100%). Manufacturers and user facilities are required to report; voluntary reports come from health professionals and the public.
Do these reports show that HeartStart MRx monitor/defib was at fault?
No. FDA states that "MDR data alone cannot be used to establish rates of events, evaluate a change in event rates over time or compare event rates between devices. The number of reports cannot be interpreted or used in isolation to reach conclusions about the existence, severity, or frequency of problems associated with devices." It adds that the reporting system "has limitations, including the potential submission of incomplete, inaccurate, untimely, unverified, or biased data." FDA adds that "a causal relationship cannot be established between product and reactions listed in a report."
How do I report a problem with a medical device?
Through FDA MedWatch (Form FDA 3500 for health professionals and consumers), or to the manufacturer. See the guide on how to report.
Where this comes from. Counts are built from the openFDA Device Adverse Event (MAUDE) bulk export released 28 Sep 2026, which holds reports FDA received through 31 Aug 2026. Brand, generic and manufacturer names are as written on the reports; product code names come from FDA's device classification. A report counts here when any device it lists carries this brand name after punctuation and capitalisation are normalised. No report narrative, lot number, patient detail or reporter identity is published. See the methodology and sources; FDA's record is authoritative, and corrections are handled within five working days.
Drug data (FAERS) through 30 Jun 2026; device data (MAUDE) through 31 Aug 2026. Not medical advice.